Cellectis (CLLS) EBT (2015 - 2026)

Cellectis (CLLS) posted quarterly EBT of -$8.8 million for Q1 2026, down 473.36% year-over-year from $2.4 million in Q1 2025, and up 91.67% quarter-over-quarter from -$106.1 million in Q4 2025.

Cellectis (CLLS) EBT (2015 - 2026) Analysis & Trends

Cellectis' EBT history runs 12 years deep, the most recent figure standing at -$8.8 million for Q1 2026.

  • In Q1 2026, EBT fell 473.36% year-over-year to -$8.8 million; the TTM figure through Mar 2026 stood at -$76.8 million (down 34.55% YoY), while the FY2025 annual figure was -$68.0 million, down 85.02% from the prior year.
  • EBT for Q1 2026 stood at -$8.8 million, up from -$106.1 million in the prior quarter.
  • The five-year high for EBT was $22.4 million in Q3 2025, with the low at -$106.1 million in Q4 2025.
  • The 5-year median for EBT is -$8.8 million (2026), against an average of -$18.3 million.
  • The sharpest annual moves came in 2023 and 2025: EBT slumped 3000.46% in 2023, then surged 191.03% in 2025.
  • Cellectis' EBT stood at -$2.8 million in 2022, then plunged by 3000.46% to -$88.0 million in 2023, then soared by 52.63% to -$41.7 million in 2024, then sank by 154.56% to -$106.1 million in 2025, then jumped by 91.67% to -$8.8 million in 2026.
  • Business Quant data shows CLLS's EBT at -$8.8 million in Q1 2026, -$106.1 million in Q4 2025, and $22.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 1.39 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 541.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -644.37 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 312.46 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -2,828.29
7 Royalty Pharma 33.72 Bn 35.84 Bn - 81.49 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 177.81 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -11.37 Mn
10 Cellectis 306.61 Mn 120.95 Mn - -8.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.83 Mn
Dec 31, 2025 -106.06 Mn
Sep 30, 2025 22.41 Mn
Jun 30, 2025 15.65 Mn
Mar 31, 2025 2.37 Mn
Dec 31, 2024 -41.66 Mn
Sep 30, 2024 7.70 Mn
Jun 30, 2024 -25.50 Mn
Mar 31, 2024 11.65 Mn
Dec 31, 2023 -87.96 Mn
Sep 30, 2023 -38.84 Mn
Jun 30, 2023 3.10 Mn
Mar 31, 2023 -17.48 Mn
Dec 31, 2022 -2.84 Mn
Sep 30, 2022 -23.37 Mn
Jun 30, 2022 -15.63 Mn
Mar 31, 2022 -5.62 Mn
Dec 31, 2021 -7.06 Mn
Sep 30, 2021 -44.56 Mn
Jun 30, 2021 -36.17 Mn